Bayley P, Cushing H: A classification
of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis.
Philadelphia, Lippincott, 1926.
Kernohan J : Pathology of the nervous
system. Vol. 2, New York: Mc Graw-Hill, 1971: 1993-2007.
Chin WW, Hazel JJ, Kim TH:
Oligodendrogliomas: A Clinical Study of Cerebral Oligodendrogliomas. Cancer 45: 1458-1466,
1980.
Russell DS: Pathology Tumours Nervous
System. ed. 5. Baltimore: Williams and Wilkins. 1989, pp 172-187.
Zülch KJ : Histological typing of
tumors of the central nevous system. International Histologycal Classification of Tumors.
Geneva: World Health Organization, 1979.
Roberts M, German W: A long term study
of patients with oligodendrogliomas: Follow-up of 50 cases, incluiding Dr. Harvey
Cushing's series. J. Neurosurgery 24: 697-700, 1966.
Brens : Pediatric and Adolescent
Oligodendrogliomas. Am. Journal Neurology 6: 1293-1295, 1993.
Burger P: The "ideal"
classifications of pediatrics nervous system neoplasm . Cancer 56: 1865-1868, 1987.
Shimizu KT, Tran LM, Mark RJ:
Management of Oligodendrogliomas. Radiology 186: 569-572, 1993.
Celli P, Notrone I, Palma J: Cerebral
Oligodendroglioma: Prognostic factors and Life History. Neurosurgery 35: 1018-1034, 1994.
Horrax G, Wu W : Postoperative
survival of patients with intracraneal oligodendrogliomas with especial reference to
radical tumor rernoval; a study of 26 patients. J Neurosurg 8: 473-479, 1951.
Winger MJ, Macdonald DR:
Supratentorial anaplastic gliomas in adults: The prognostic importance of extent of
resection and prior low grade glioma. J Neurosurgery 71: 487-493,1989.
Bullard DE, Rawlings CE, Halperin EC:
Oligodendroglioma, an analysis of the value of radiation therapy. Cancer 60: 2179-2188,
1987.
Sheline G: Radiation therapy of brain
tumors. Cancer 39: 873-881, 1977.
Wallner K: The treatment
oligodendrogliomas with or without postop irradiation. J Neuros 68: 684-688, 1988.
Cairncross JG: Successful chemotherapy
recurrent malignant oligodendroglioma. Neurol 38: 724-26,1988.
Glass J, Hochberg F, Gruber M : The
Treatment of Oligodendroglioma Mixed: Oligoastrocytoma with Procarbazina, Vincristina y
Nitrosourea (PVC) Chemotherapy. Journal of Neurosurgery 76: 741-745, 1992.
Levin VA, Wara WM, Davis RL: Phase III
comparison of BCNU [bis-(2-cloroethyl)-1-niotrosourea)] and the combination of
procarbazine, CCNU [methyl-1-(2-cloroethyl)- 1 -nitrosourea)] y Vincristina administered
after radiotherapy with hydroxyurea for malignant gliomas. Journal of Neurosurgery 63: 218-223,
1985.
Karnofski D: The Clinical Evaluation
of Chemotherapeutic Agents in cancer. New York: Columbia University Press, 1949, pp 191-205.
Kaplan E.L, Meier P. : Nonparametric
estimation from incomplete observations. J. Am. Statistical Associaton 53: 457-581, 1958.
SPSS, versión 6,1 para Windows 98.
Smith MT, Ludwig CL, Godfrey AD:
Grading of Oligodendrogliomas. Cancer 52: 2107-2114, 1983.
Freeman L, Felgin I: Oligodendroglioma
with 35-year Survival. Journal of Neurosurgery 20: 363-365, 1963.
Hirsch J : Bening Astrocytic and
Oligodendrcytic tumors of the cerebral hemispheres in children. Journal of Neurosurgery
79: 568-572, 1989.
Yournans JR (ed): Neurological
Surgery, second edition. Philadelphia: WB Saunders, Vol 4, 1982.
Lindegaard KF, Mork SJ, Ganz J:
Statistical analysis of clinocopathological features, radiotherapy and survival in 170
cases of oligodendroglioma. Journal of Neurosurgery 67: 224-230, 1987.
Sun ZM: Factors possibly influencing
the prognosis of oligodendroglioma. Neurosurgery 22: 886-890, 1988.
Landa R: Gliomas cerebrales. INEN-Lima-Perú.
Tesis de Doctorado en Medicina Humana. UNMSM, 1963.
Roca E: Estudio de 103 gliomas
cerebrales. Revista de Neuropsiquiatría 29:226-255, 1966.
WeirB, ElvidgeA: Oligodendrogliomas:
analysis of 63 cases. Journal of Neurosurgery 29: 500-505, 1968.
